Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Clostridioides difficile Infection in a Japanese Tertiary Children's Hospital

  • Meguro, Mariko (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) ;
  • Nambu, Ryusuke (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) ;
  • Hara, Tomoko (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) ;
  • Ebana, Ryo (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) ;
  • Yoshida, Masashi (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) ;
  • Yamamoto, Saki (Department of Laboratory Technology, Saitama Children's Medical Center) ;
  • Mori, Koki (Department of Laboratory Technology, Saitama Children's Medical Center) ;
  • Iwama, Itaru (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center)
  • Received : 2022.05.09
  • Accepted : 2022.07.28
  • Published : 2022.09.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Toxins produced by Clostridioides difficile infection (CDI) can cause enteritis and diarrhea. Although the number of pediatric CDI cases is increasing, the clinical management of pediatric CDI, including patient characteristics and prognosis, remains unclear. This study aimed to elucidate the background and clinical course of patients with CDI and evaluate the reliability of diagnostic tests in a tertiary pediatric hospital in Japan. Methods: We retrospectively analyzed the clinical data of children diagnosed with CDI between 2011 and 2021 at the Saitama Children's Medical Center in Saitama, Japan. Results: During the study period, 1,252 C. difficile antigen/toxin tests were performed, and 37 patients were diagnosed with CDI. The main underlying diseases among the patients were hematological and malignant disorders and gastrointestinal diseases, including inflammatory bowel disease (IBD) (59.4%). Two patients (5.4%) had an unremarkable medical history. Among the 37 patients, 27 (73.0%) were immunocompromised, 25 (67.6%) had a history of antibiotic use within the past two months, and 6 (16.2%) were negative on the initial test but were positive on the second test. Finally, 28 patients (75.7%) required primary antibiotic therapy only, and two patients with IBD required additional antibiotic therapy as secondary treatment. Conclusion: The number of pediatric patients with CDI is increasing. Both a comprehensive interview, including underlying diseases and history of antibiotic use, and an understanding of the features of clinical examinations should be emphasized to appropriately diagnose and treat CDI.

Keywords

Acknowledgement

The authors thank Dr. Shohei Takahashi, Dr. Mei Haruyama, and Ms. Funa Akai at the Saitama Children's Medical Center.

References

  1. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008;46 (Suppl 1):S12-8. https://doi.org/10.1086/521863
  2. Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001;7:405-10. https://doi.org/10.1046/j.1198-743x.2001.00289.x
  3. Gnocchi M, Gagliardi M, Gismondi P, Gaiani F, De' Angelis GL, Esposito S. Updated management guidelines for Clostridioides difficile in paediatrics. Pathogens 2020;9:291.
  4. Corrigan RA, Sithamparanathan K, Kenny C, Wong THN. Usefulness of the Bristol Stool Form Chart scoring system for the laboratory processing of faecal samples in suspected Clostridioides difficile cases. J Hosp Infect 2020;105:95-7. https://doi.org/10.1016/j.jhin.2019.12.005
  5. Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile Infection in children. JAMA Pediatr 2013;167:567-73. https://doi.org/10.1001/jamapediatrics.2013.441
  6. Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013;26:604-30. https://doi.org/10.1128/CMR.00016-13
  7. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficileinfection (CDI). Clin Microbiol Infect 2009;15:1053-66. https://doi.org/10.1111/j.1469-0691.2009.03098.x
  8. Kawada M, Annaka M, Kato H, Shibasaki S, Hikosaka K, Mizuno H, et al. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection. J Infect Chemother 2011;17:807-11. https://doi.org/10.1007/s10156-011-0267-5
  9. Senoh M, Kato H, Honda H, Fukuda T, Tagashira Y, Horiuchi H, et al. Performance of laboratory tests for detection for Clostridioides difficile: a multicenter prospective study in Japan. Anaerobe 2019;60:102107.
  10. Guidelines for the treatment of Clostridioides (Clostridium) difficile infections [Internet]. Tokyo: CDI Clinical Practice Guideline Development Committee; 2018 [cited 2022 Apr 21]. Available from: https://www.chemotherapy.or.jp/modules/guideline/index.php?content_id=96#pdf
  11. van Prehn J, Vandenbroucke-Grauls CM, van Beurden YH, van Houdt R, Vainio S, Ang CW. Diagnostic yield of repeat sampling with immunoassay, real-time PCR, and toxigenic culture for the detection of toxigenic Clostridium difficile in an epidemic and a non-epidemic setting. Eur J Clin Microbiol Infect Dis 2015;34:2325-30. https://doi.org/10.1007/s10096-015-2484-9
  12. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370:1198-208. Erratum in: N Engl J Med 2022;386:2348.
  13. Revolinski SL, Munoz-Price LS. Clostridium difficile in immunocompromised hosts: a review of epidemiology, risk factors, treatment, and prevention. Clin Infect Dis 2019;68:2144-53. https://doi.org/10.1093/cid/ciy845
  14. Perumalsamy S, Riley TV. Molecular epidemiology of Clostridioides difficile infections in children. J Pediatric Infect Dis Soc 2021;10 (Suppl 3):S34-40. https://doi.org/10.1093/jpids/piab057
  15. Salamonowicz M, Ociepa T, Fraczkiewicz J, Szmydki-Baran A, Matysiak M, Czyzewski K, et al. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation. Eur J Clin Microbiol Infect Dis 2018;37:1805-12. https://doi.org/10.1007/s10096-018-3316-5
  16. Martinelli M, Strisciuglio C, Veres G, Paerregaard A, Pavic AM, Aloi M, et al. Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study. Inflamm Bowel Dis 2014;20:2219-25. https://doi.org/10.1097/MIB.0000000000000219
  17. Wilcox MH. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterol 2003;17:475-93. https://doi.org/10.1016/S1521-6918(03)00017-9
  18. Schroeder MS. Clostridium difficile--associated diarrhea. Am Fam Physician 2005;71:921-8.
  19. Deshpande A, Pasupuleti V, Patel P, Ajani G, Hall G, Hu B, et al. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield. Clin Gastroenterol Hepatol 2011;9:665-9.e1. https://doi.org/10.1016/j.cgh.2011.04.030
  20. Gateau C, Couturier J, Coia J, Barbut F. How to: diagnose infection caused by Clostridium difficile. Clin Microbiol Infect 2018;24:463-8. https://doi.org/10.1016/j.cmi.2017.12.005
  21. Yin J, Kociolek LK, Same RG, Hsu AJ, Amoah J, Tamma PD. Oral vancomycin may be associated with earlier symptom resolution than metronidazole for hospitalized children with nonsevere Clostridiodes difficile infections. Open Forum Infect Dis 2019;6:ofz492. Erratum in: Open Forum Infect Dis 2020;7:ofaa041.
  22. Senoh M, Kato H, Fukuda T, Niikawa A, Hori Y, Hagiya H, et al. Predominance of PCR-ribotypes, 018 (smz) and 369 (trf ) of Clostridium difficile in Japan: a potential relationship with other global circulating strains? J Med Microbiol 2015;64:1226-36. https://doi.org/10.1099/jmm.0.000149
  23. Chandrakumar A, Zohni H, El-Matary W. Clostridioides difficile infection in children with inflammatory bowel disease. Inflamm Bowel Dis 2020;26:1700-6. https://doi.org/10.1093/ibd/izz285